Le Lézard
Classified in: Health, Science and technology, Business
Subject: SVY

Boosting Digital Marketing Impact on Pharmaceutical Product Launches through Effective Hiring of Digital Marketing Talent


CHAPEL HILL, N.C., Feb. 23, 2018 /PRNewswire/ -- As digital marketing strategies and tactics evolve in the pharmaceutical industry, companies are fine-tuning how they hire and develop new digital marketing talent.

A Best Practices, LLC study on digital marketing impact found, however, that hiring strategies differ based on company size.

Larger companies covet "interpersonal" and "analytical" skills most in new digital hires, traits which are critical for successfully navigating organizational size and complexity.  For smaller companies, ideal digital marketers must not only serve as ambassadors (interpersonally) and marketers (analytically), but as entrepreneurs be able to draw on healthcare and tech experience to build workable engagement frameworks and make new tools and systems operational, according to the study.

The topic of hiring digital marketing talent is one of many issues addressed in the study, which provides a snapshot of current approaches to improving the impact of digital marketing. The benchmarking research project engaged 31 digital marketing leaders at 24 companies.

The study examines how savvy biopharma digital marketers are enhancing the medical and commercial potential of new products, improving alignment with brand teams, and acquiring and training new digital marketers. The wide-ranging research also examines how digital marketing groups are structured and aligned internally, what services or activities they are most involved with and how they manage and utilize vendors.

"Growing Biopharma Digital Marketing Impact: Digitizing Launch, Developing Talent and Optimizing Service Alignment" is a report that examines a host of key digital marketing operational benchmarks required to achieve best-in-class performance and to foster a stronger digital culture throughout the organization. This 55-page study will serve as a resource for driving digital marketing performance excellence in the healthcare industry.

Topics addressed in the study include:

Download a complimentary report summary at: http://www.best-in-class.com/rr1486.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

 

SOURCE Best Practices, LLC


These press releases may also interest you

at 01:38
The Barcelona R&D Center ("the Center") of Wanhua Chemical (SHA:600309; "the Company"), located at Cornella de Llobregat, has officially opened its doors as a pivotal move by the company to advance its footprint in Europe and beyond with a quicker...

at 01:35
Regulatory News: Pernod Ricard (Paris:RI): Press Release ? Paris, 25 April 2024 This robust performance illustrates the strength of our diversified portfolio of premium international spirits and our broad-based geographic footprint covering...

at 01:30
Happiest Minds Technologies Limited (NSE: HAPPSTMNDS), a 'Born Digital. Born Agile', Mindful IT Company, today announced it signed definitive agreements to acquire 100% of the equity share capital of PureSoftware Technologies Private Limited...

at 01:21
Aker Solutions has delivered strong revenue growth and improved profitability in the first quarter of 2024 compared to the same period last year. With a solid backlog and high tendering activity, the company is well positioned for future profitable...

at 01:18
First Quarter Highlights            HMH delivered an EBITDA (adj.) of USD 33 million in quarter, about 75% increase year-over-year driven by higher aftermarket activityNES Fircroft delivered 17% increase in EBITDA and 12% revenue growth...

at 01:17
Quarter 1, 2024 - High profitability and strong cash flow Net sales decreased 4.1% to SEK 34,850m (36,352)Organic growth amounted to -4.0%, of which volume accounted for -1.8% and price/mix -2.2%. Excluding restructuring and exited contracts, volumes...



News published on and distributed by: